XPO Operating Cash Flow decreased by 19.0% to $183.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 28.9%, from $142.00M to $183.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 10.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $462.00M | $19.00M | $98.00M | $200.00M | $157.00M | $271.00M | $196.00M | $76.00M | $131.00M | $236.00M | $251.00M | $145.00M | $210.00M | $264.00M | $189.00M | $142.00M | $247.00M | $371.00M | $226.00M | $183.00M |
| QoQ Change | — | -95.9% | +415.8% | +104.1% | -21.5% | +72.6% | -27.7% | -61.2% | +72.4% | +80.2% | +6.4% | -42.2% | +44.8% | +25.7% | -28.4% | -24.9% | +73.9% | +50.2% | -39.1% | -19.0% |
| YoY Change | — | — | — | — | -66.0% | >999% | +100.0% | -62.0% | -16.6% | -12.9% | +28.1% | +90.8% | +60.3% | +11.9% | -24.7% | -2.1% | +17.6% | +40.5% | +19.6% | +28.9% |